- timulants
- Amphetamines
- Methylphenidate
- Dextroamphetamine
- Dexmethylphenidate
- Non-Stimulants
- Atomoxetine
- Bupropion
- Guanfacine
Attention Deficit Hyperactivity Treatment Disorder Market size is valued at USD 21.14 billion in 2022 and is expected to reach USD 30.20 billion by 2029, at a CAGR of 6.22% during the forecast period 2023-2029. A neurodevelopmental illness, Attention-Deficit Hyperactivity Disorder , is most typically diagnosed in children, although it also affects teenagers and adults. A person with ADHD may be hyperactive and unable to regulate their impulses, or they may struggle to focus. Short attention span or being quickly distracted are symptoms of ADHD, as are restlessness, persistent fidgeting or over activity, and impulsivity. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).
Global Attention Deficit Hyperactivity Treatment Disorder Adhd Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
6.22%
Largest Market
North-America
Fastest Growing Market
Europe
Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market Dynamics
The industry's current and future market outlook in light of recent changes, including growth possibilities and drivers, as well as difficulties and restraints in both emerging and developed markets.
Attention Deficit Hyperactivity Treatment Disorder Adhd Market Regional Analysis
North-America Got Significant Share
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Attention Deficit Hyperactivity Treatment Disorder Adhd Market Segmentation
By Medication Type
By Age Group
- Paediatric
- Adolescent
- Adults
Distribution Channel
- Hospital pharmacies
- Specialty clinics
- Retail pharmacies
- Online pharmacies
Frequently Asked Questions
Attention Deficit Hyperactivity Treatment Disorder Market size is valued at USD 21.14 billion in 2022 and is expected to reach USD 30.20 billion by 2029, at a CAGR of 6.22% during the forecast period 2023-2029
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market Introduction |
| 2.1.Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market - Taxonomy |
| 2.2.Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market - Definitions |
| 2.2.1.Medication Type |
| 2.2.2.Age Group |
| 2.2.3.Distribution Channel |
| 2.2.4.Region |
| 3.Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market By Medication Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. timulants |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Non-Stimulants |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market By Age Group, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Paediatric |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Adolescent |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Adults |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Hospital pharmacies |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Specialty clinics |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Retail pharmacies |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Online pharmacies |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Medication Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.timulants |
| 9.1.2.Non-Stimulants |
| 9.2. Age Group Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Paediatric |
| 9.2.2.Adolescent |
| 9.2.3.Adults |
| 9.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospital pharmacies |
| 9.3.2.Specialty clinics |
| 9.3.3.Retail pharmacies |
| 9.3.4.Online pharmacies |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Medication Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.timulants |
| 10.1.2.Non-Stimulants |
| 10.2. Age Group Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Paediatric |
| 10.2.2.Adolescent |
| 10.2.3.Adults |
| 10.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospital pharmacies |
| 10.3.2.Specialty clinics |
| 10.3.3.Retail pharmacies |
| 10.3.4.Online pharmacies |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Medication Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.timulants |
| 11.1.2.Non-Stimulants |
| 11.2. Age Group Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Paediatric |
| 11.2.2.Adolescent |
| 11.2.3.Adults |
| 11.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospital pharmacies |
| 11.3.2.Specialty clinics |
| 11.3.3.Retail pharmacies |
| 11.3.4.Online pharmacies |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Medication Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.timulants |
| 12.1.2.Non-Stimulants |
| 12.2. Age Group Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Paediatric |
| 12.2.2.Adolescent |
| 12.2.3.Adults |
| 12.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospital pharmacies |
| 12.3.2.Specialty clinics |
| 12.3.3.Retail pharmacies |
| 12.3.4.Online pharmacies |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Medication Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.timulants |
| 13.1.2.Non-Stimulants |
| 13.2. Age Group Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Paediatric |
| 13.2.2.Adolescent |
| 13.2.3.Adults |
| 13.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospital pharmacies |
| 13.3.2.Specialty clinics |
| 13.3.3.Retail pharmacies |
| 13.3.4.Online pharmacies |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Allergan, Inc. (U.S.) |
| 14.2.2.Medtronic. (Covidien PLC) (U.S.) |
| 14.2.3.EnteroMedics, Inc (U.S.) |
| 14.2.4.Cousin Biotech (France) |
| 14.2.5.Surgical IOC (Peters Surgical SAS) (France) |
| 14.2.6.PARE Surgical Inc. (U.S.) |
| 14.2.7.GI Dynamics (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Allergan, Inc. (U.S.)
- Medtronic. (Covidien PLC) (U.S.)
- EnteroMedics, Inc (U.S.)
- Cousin Biotech (France)
- Surgical IOC (Peters Surgical SAS) (France)
- PARE Surgical Inc. (U.S.)
- GI Dynamics (U.S.)